| PtI 2 (DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features D Cirri, S Pillozzi, C Gabbiani, J Tricomi, G Bartoli, M Stefanini, ... Dalton Transactions 46 (10), 3311-3317, 2017 | 42 | 2017 |
| Ball milled glyco-graphene oxide conjugates markedly disrupted Pseudomonas aeruginosa biofilms J Tricomi, M Cacaci, G Biagiotti, L Caselli, L Niccoli, R Torelli, A Gabbani, ... Nanoscale 14 (28), 10190-10199, 2022 | 5 | 2022 |
| Carbohydrate functionalized quantum dots in sensing, imaging and therapy applications M Marradi, J Tricomi, C Matassini, B Richichi Carbohydrate Functionalized Quantum Dots in Sensing, Imaging and Therapy …, 2021 | 5 | 2021 |
| Fucosyltransferase-specific inhibition via next generation of fucose mimetics KC Martin, J Tricomi, F Corzana, A García-García, L Ceballos-Laita, ... Chemical Communications 57 (9), 1145-1148, 2021 | 3 | 2021 |
| Glycans meet sphingolipids: Structure-based design of glycan containing analogues of a sphingosine kinase inhibitor A Papakyriakou, F Cencetti, E Puliti, L Morelli, J Tricomi, P Bruni, ... ACS Medicinal Chemistry Letters 11 (5), 913-920, 2020 | 3 | 2020 |
| Stereoselective Synthesis of the Gal‐α‐(1→ 3)‐Gal‐β‐(1→ 3)‐GlcNAc Trisaccharide: a new Ligand for DCAR and Mincle C‐Type Lectin Receptors J Tricomi, M Aoun, B Xu, R Holmdahl, B Richichi ChemBioChem 25 (9), e202400026, 2024 | | 2024 |
| Rational design, synthesis, and pharmacological evaluation of a cohort of novel beta-adrenergic receptors ligands enables an assessment of structure-activity relationships J Tricomi, L Landini, V Nieddu, U Cavallaro, JG Baker, A Papakyriakou, ... European Journal of Medicinal Chemistry 246, 114961, 2023 | | 2023 |
| A new generation of β-adrenergic receptor (β-ARs) ligands: rational design, synthesis, and pharmacological evaluation J Tricomi | | 2023 |
